Support Progresses for Medical Research Programs in Congress
Momentum is building across Congress and the research community in strong support of increased federal investment in medical research at both...
Stories & News
Late-Breaking Data at EULAR Shows Investigational Drug Nipocalimab Significantly Reduces Disease Activity in Lupus
The Lupus Research Alliance is encouraged by positive late-breaking Phase 2 data with nipocalimab, an investigational drug in development by Johnson & Johnson showing significantly reduced disease activity in...
Positive Results of Phase 3 Dapirolizumab Pegol Trial in Systemic Lupus Erythematosus Shown in Published Paper
The Lupus Research Alliance welcomes additional positive results from the Phase 3 PHOENYCS GO study showing that combined with standard care, investigational dapirolizumab pegol (DZP) in...
Introducing the “Hope in Action” Fireside Chat Series
Watch Episode 1 On Demand Here
Progress in lupus research is accelerating, bringing new momentum, new possibilities, and new hope...
Nancy Mize Gonzalez: Putting Passion into Action
Nancy Mize Gonzalez did not set out to build a career around lupus. She set out to follow her...
LRA Progress & Purpose Update | Albert T. Roy – May 2026
Hear from President and CEO Albert T. Roy as he recaps the organization’s activations from Lupus Awareness, shining a...
Learning About Lupus in the Asian American & Pacific Islander Populations
May marks Lupus Awareness Month – but it is also a month to honor Asian American and Pacific Islander...
Tell Congress Why Lupus Research Funding Must be a Priority
With your help, the Lupus Research Alliance has become the world’s largest funder of lupus research. The Lupus Research...
House Appropriations Committee Supports Lupus ABC
Great news! With a unanimous, bipartisan vote, the House Appropriations Committee adopted a provision supporting the Lupus Accelerating Breakthroughs...
Letter from LRA President & CEO Albert T. Roy
Dear Friends,
Lupus Awareness Month begins today, and with it comes a renewed sense of purpose, momentum, and possibility. Thanks...
Saphnelo™ Approved as Self-Administered Autoinjector
The U.S. Food and Drug Administration just granted approval for a self-administered, once-weekly autoinjector of Saphenlo (anifrolumab), for the treatment of adult patients...
Debbie Schwartz: Advocating in Every Sense of the Word
Debbie Schwartz is absolutely convinced that a cure for lupus will be found in her lifetime.
Why? Because she’s done something like this once before.
Debbie previously dealt with epileptic...